影响状细胞形成的CDKL1变体倾向于发生胸前大动脉动脉瘤和剖析
Theresa Nauth1, Melanie Philipp2, Sina Renner1
1Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
The Journal of clinical investigation
|October 7, 2025
概括
CDKL1基因中的新遗传变异与胸前大动脉动脉瘤和解剖 (TAAD) 疾病有关. 这些发现揭示了CDKL1在大动脉健康和毛功能中的作用.
科学领域:
- 心血管遗传学 心血管遗传学
- 分子生物学分子生物学
- 乳生物学的生物学
背景情况:
- 遗传因素是胸前大动脉动脉瘤和解剖 (TAAD) 病因的关键,但在大多数患者中病因仍未知.
- 识别新的遗传变异对于理解TAAD病原体至关重要.
- 在TAAD中CDKL1的作用以前未被探索.
研究的目的:
- 为了识别与TAAD相关的未报告的序列变异.
- 调查已识别的CDKL1变异的功能影响.
- 探索CDKL1在大动脉疾病和初级毛功能中的作用.
主要方法:
- 在323名TAAD患者的外体和基因面板测序.
- 斑马鱼的功能研究 (敲击/敲击和RNA救援).
- 实验室研究评估变异对蛋白质功能,乳毛和信号通路的影响.
主要成果:
- 在6名来自3个TAAD谱系障碍患者家庭的6名患者中发现了异构的CDKL1变异.
- CDKL1变异影响了激酶活性,蛋白质结合,乳毛形成和信号通路 (p38 MAPK,Vegf).
- 斑马鱼模型中Cdkl1被淘汰,呈现出大动脉扩张和ISV缺陷,这些缺陷被野生类型CDKL1RNA所挽救.
结论:
- CDKL1变种与TAAD谱系疾病的发病有关.
- 由于CDKL1变体导致的初级眼失调有助于TAAD.
- 这项研究扩大了对TAAD病理生理学的理解,将其与状腺功能障碍联系起来.
更多相关视频
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
34.6K
05:31Murine Model of Thoracic Aortic Dissection Induced by Oral β-Aminopropionitrile and Subcutaneous Angiotensin II Infusion
Published on: May 16, 2025
829
相关概念视频
01:30Coronary Artery Disease I: Introduction
878
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
878
01:30Aneurysm I: Introduction
366
An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
366
01:21Aneurysm II: Clinical Manifestations and Diagnostic Studies
293
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
293
01:09Cytoskeletal Linker Proteins - Plakins
2.8K
Plakins are large proteins with binding domains for microtubules, microfilaments, intermediate filaments, and membrane-associated protein complexes at cell junctions. Plakin functions are evolutionarily conserved and are primarily involved in organizing the different components of the cytoskeleton by crosslinking them to each other and connecting them to the cell-matrix and cell adhesion complexes. They are also known to interact with signal transducers, serve as scaffolds for signaling...
2.8K
01:26Coronary Artery Disease II: Pathophysiology
367
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
367
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
401
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
401